Company Overview
CHEMOMAB THERAPEUTICS LTD.
CMMBRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
—M
2022 FY
Net Income
-28M
2022 FY
Shares Outstanding
228M
2022 FY
EPS
0.121USD
2022 FY
Company Information
SIC Code
2834
CIK Code
1534248
Exchange
Nasdaq
Location
IL